Form 15-12G - Securities registration termination [Section 12(g)]
2023年11月14日 - 6:08AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
15
Certification
and Notice of Termination of Registration
under
Section 12(g) of the Securities Exchange Act of 1934
or
Suspension of Duty to File Reports Under Sections 13 and 15(d)
of
the Securities Exchange Act of 1934.
Commission
File Number: 001-38832
SURGALIGN
HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
520
Lake Cook Road, Suite 315
Deerfield,
Illinois
(877)
343-6832
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common
Stock, par value $0.001 per share
(Title
of each class of securities covered by this Form)
None
(Titles
of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1) |
☒ |
|
Rule 12g-4(a)(2) |
☐ |
|
Rule 12h-3(b)(1)(i) |
☒ |
|
Rule 12h-3(b)(1)(ii) |
☐ |
|
Rule 15d-6 |
☐ |
|
Rule 15d-22(b) |
☐ |
Approximate
number of holders of record as of the certification or notice date:
Common
Stock, par value $0.01 per share: Zero
EXPLANATORY
NOTE
On
June 19, 2023, Surgalign Holdings, Inc. (the “Company”)
and certain of its direct and indirect subsidiaries commenced voluntary proceedings under chapter
11 (the “Chapter 11 Cases”) of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern
District of Texas. The Chapter 11 Cases are being jointly administered under the caption In re Surgalign Holdings, Inc., et al.,
Case Nos. 23-90730 through 23-90737.
On
October 2, 2023 (the “Effective Date”), the Company’s modified combined disclosure statement and joint chapter
11 plan of liquidation (the “Plan”) became effective. Pursuant to the Plan, all equity interests in the Company, including
the common stock of the Company, were cancelled on the Effective Date and shall be of no further force and effect, whether surrendered
for cancellation or otherwise. As a result, as of October 2, 2023, there are no holders of common stock of the Company.
Pursuant
to the requirements of the Securities Exchange Act of 1934, Surgalign Holdings, Inc. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.
Date:
November 13, 2023
|
SURGALIGN HOLDINGS, INC. |
|
|
|
|
|
By: |
/s/ Steven Balasiano |
|
|
Name: |
Steven Balasiano |
|
|
Title: |
Authorized Signatory |
Surgalign (PK) (USOTC:SRGAQ)
過去 株価チャート
から 5 2024 まで 6 2024
Surgalign (PK) (USOTC:SRGAQ)
過去 株価チャート
から 6 2023 まで 6 2024